Search results
Human babesiosis is a zoonotic infection caused by Babesia parasites transmitted by the bite of ixodid ticks that have distinct geographical distributions based on the presence of their competent natural animal hosts, which include rodents, cattle and deer.
30 lis 2020 · III. What Are the Preferred Treatment Regimens for Babesiosis? Recommendation: We recommend treating babesiosis with the combination of atovaquone plus azithromycin or the combination of clindamycin plus quinine (strong recommendation, moderate-quality evidence).
1 wrz 2021 · The current arsenal for the treatment of human babesiosis relies principally on four drugs: atovaquone, azithromycin, clindamycin, and quinine. Atovaquone is used to treat several human diseases, including Pneumocystis jirovecii pneumonia , toxoplasmosis , and malaria (in combination with proguanil (Malarone) .
21 cze 2012 · This review article discusses the epidemiology, transmission, clinical manifestations, parasite life cycle, immunology, diagnosis, and treatment of babesiosis, a tickborne zoonosis.
A high index of clinical suspicion in residents of endemic areas or individuals who had a recent travel history to such areas, with laboratory confirmation can guide an early institution of appropriate antimicrobial therapy, thereby preventing complications and death. KEY WORDS: Babesia, diagnosis, management.
Most cases of human babesiosis are successfully treated with atovaquone and azithromycin or clindamycin and quinine. Severe disease may require prolonged treatment.
30 lis 2020 · A new evidence-based clinical practice guideline for the prevention, diagnosis and treatment of the worldwide disease caused by Babesia parasites has been published in Clinical Infectious Diseases.
